Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123983732 | 12398373 | 2 | F | 20141124 | 20160914 | 20160524 | 20160921 | EXP | DE-JNJFOC-20150402191 | JANSSEN | 50.00 | YR | A | F | Y | 66.00000 | KG | 20160921 | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123983732 | 12398373 | 1 | SS | REMICADE | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | N | 0 | LYOPHILIZED POWDER | |||||||||
| 123983732 | 12398373 | 2 | SS | REMICADE | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | N | 0 | LYOPHILIZED POWDER | |||||||||
| 123983732 | 12398373 | 3 | SS | REMICADE | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | N | 0 | LYOPHILIZED POWDER | |||||||||
| 123983732 | 12398373 | 4 | PS | REMICADE | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | N | 103772 | LYOPHILIZED POWDER | |||||||||
| 123983732 | 12398373 | 5 | C | SALOFALK | MESALAMINE | 1 | Unknown | D | 0 | 1.5 | MG | UNSPECIFIED | QD | ||||||
| 123983732 | 12398373 | 6 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Unknown | D | 0 | 5 | MG | UNSPECIFIED | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123983732 | 12398373 | 1 | Crohn's disease |
| 123983732 | 12398373 | 2 | Crohn's disease |
| 123983732 | 12398373 | 3 | Crohn's disease |
| 123983732 | 12398373 | 4 | Crohn's disease |
| 123983732 | 12398373 | 5 | Crohn's disease |
| 123983732 | 12398373 | 6 | Crohn's disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123983732 | 12398373 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123983732 | 12398373 | Abdominal adhesions | |
| 123983732 | 12398373 | Arthropathy | |
| 123983732 | 12398373 | Crohn's disease | |
| 123983732 | 12398373 | Diarrhoea | |
| 123983732 | 12398373 | Hypertension | |
| 123983732 | 12398373 | Intestinal resection | |
| 123983732 | 12398373 | Vision blurred |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123983732 | 12398373 | 1 | 20150106 | 0 | ||
| 123983732 | 12398373 | 2 | 20140428 | 0 | ||
| 123983732 | 12398373 | 3 | 20141202 | 0 | ||
| 123983732 | 12398373 | 4 | 20160509 | 0 | ||
| 123983732 | 12398373 | 5 | 20131112 | 0 | ||
| 123983732 | 12398373 | 6 | 20131112 | 0 |